-
公开(公告)号:US20230193229A1
公开(公告)日:2023-06-22
申请号:US17841639
申请日:2022-06-15
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Joseph M. Jacobson
IPC: C12N9/22 , C12N15/90 , C12N15/10 , C12N15/113 , C12N15/85
CPC classification number: C12N9/22 , C12N15/907 , C12N15/102 , C12N15/113 , C12N15/85 , C12N2310/20
Abstract: SpRYc is a grafted ScCas9++-SpRY chimeric Cas9 possessing minimal 5′-NNN-3′ PAM specificity. SpRYc comprises the N-terminus (residues 1-1119) of ScCas9++ (Sc++), including the flexible loop, followed by the region of SpRY (residues 1111-1368) spanning its PAM-interacting domain mutations. Methods of altering gene expression include use of SpRYc in complex with guide RNA in a CRISPR-Cas9 system.
-
公开(公告)号:US20250154513A1
公开(公告)日:2025-05-15
申请号:US18927790
申请日:2024-10-25
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Noah Michael Jakimo , Joseph M. Jacobson
Abstract: Applications of a Streptococcus Cas9 ortholog from Streptococcus macacae (Smac Cas9), possessing minimal adenine-rich PAM specificity, include an isolated Streptococcus macacae Cas9 protein or transgene expression thereof, a CRISPR-associated DNA endonuclease with PAM interacting domain amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein, and an isolated, engineered Streptococcus pyogenes Cas9 (Spy Cas9) protein with a PID as either the PID amino acid composition of the isolated Streptococcus macacae Cas9 (Smac Cas9) protein or of a CRISPR-associated DNA endonuclease with PID amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein. A method for altering expression of at least one gene product employs Streptococcus macacae Cas9 endonucleases in complex with guide RNA, for specific recognition and activity on a DNA target immediately upstream of either an “NAA” or “NA” or “NAAN” PAM sequence.
-
公开(公告)号:US11453865B2
公开(公告)日:2022-09-27
申请号:US16689071
申请日:2019-11-19
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Noah Michael Jakimo , Joseph M. Jacobson
Abstract: Engineered Streptococcus canis Cas9 (ScCas9) variants include an ScCas9 protein with its PID being the PID amino acid composition of Streptococcus pyogenes Cas9 (SpCas9)-NG, an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 in its amino acid sequence (Sc+), and an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 and a substitution of residues ADKKLRKRSGKLATE [SEQ ID No. 4] in position 365-379 in the ScCas9 open reading frame (Sc++). Also included are CRISPR-associated DNA endonucleases with a PAM specificity of 5′-NG-3′ or 5′-NNG-3′ and a method of altering expression of a gene product by utilizing the engineered ScCas9 variants.
-
公开(公告)号:US20220162620A1
公开(公告)日:2022-05-26
申请号:US17053713
申请日:2019-05-06
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Noah Michael Jakimo , Joseph M Jacobson
Abstract: Applications of a Streptococcus Cas9 ortholog from Streptococcus macacae (Smac Cas9), possessing minimal adenine-rich PAM specificity, include an isolated Streptococcus macacae Cas9 protein or transgene expression thereof, a CRISPR-associated DNA endonuclease with PAM interacting domain amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein, and an isolated, engineered Streptococcus pyogenes Cas9 (Spy Cas9) protein with a PID as either the PID amino acid composition of the isolated Streptococcus macacae Cas9 (Smac Cas9) protein or of a CRISPR-associated DNA endonuclease with PID amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein. A method for altering expression of at least one gene product employs Streptococcus macacae Cas9 endonucleases in complex with guide RNA, for specific recognition and activity on a DNA target immediately upstream of either an “NAA” or “NA” or “NAAN” PAM sequence.
-
公开(公告)号:US20230028069A1
公开(公告)日:2023-01-26
申请号:US17683299
申请日:2022-02-28
Applicant: Massachusetts Institute of Technology
Inventor: Joseph M. Jacobson , Noah Michael Jakimo , Pranam Chatterjee
Abstract: A Streptococcus canis Cas9 (ScCas9) ortholog and its engineered variants, possessing novel PAM specificity, is an addition to the family of CRISPR-Cas9 systems. ScCas9 endonuclease is used in complex with guide RNA, consisting of identical non-target-specific sequence to that of the guide RNA SpCas9, for specific recognition and activity on a DNA target immediately upstream of either an “NNGT” or “NNNGT” PAM sequence. A novel DNA-interacting loop domain within ScCas9, and other Cas9 orthologs, such as those from Streptococcus gordonii and Streptococcus angionosis facilitates a divergent PAM sequence from the “NGG” PAM of SpCas9.
-
6.
公开(公告)号:US20200332271A1
公开(公告)日:2020-10-22
申请号:US16689071
申请日:2019-11-19
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Noah Michael Jakimo , Joseph M. Jacobson
Abstract: Engineered Streptococcus canis Cas9 (ScCas9) variants include an ScCas9 protein with its PID being the PID amino acid composition of Streptococcus pyogenes Cas9 (SpCas9)-NG, an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 in its amino acid sequence (Sc+), and an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 and a substitution of residues ADKKLRKRSGKLATE in position 365-379 in the ScCas9 open reading frame (Sc++). Also included are CRISPR-associated DNA endonucleases with a PAM specificity of 5′-NG-3′ or 5′-NNG-3′ and a method of altering expression of a gene product by utilizing the engineered ScCas9 variants.
-
公开(公告)号:US20190218532A1
公开(公告)日:2019-07-18
申请号:US16136238
申请日:2018-09-19
Applicant: Massachusetts Institute of Technology
Inventor: Joseph M. Jacobson , Noah Michael Jakimo , Pranam Chatterjee
CPC classification number: C12N9/22 , C12N1/00 , C12N15/09 , C12N15/102 , C12N15/11 , C12N15/66 , C12N2310/20
Abstract: A Streptococcus canis Cas9 (ScCas9) ortholog and its engineered variants, possessing novel PAM specificity, is an addition to the family of CRISPR-Cas9 systems. ScCas9 endonuclease is used in complex with guide RNA, consisting of identical non-target-specific sequence to that of the guide RNA SpCas9, for specific recognition and activity on a DNA target immediately upstream of either an “NNGT” or “NNNGT” PAM sequence. A novel DNA-interacting loop domain within ScCas9, and other Cas9 orthologs, such as those from Streptococcus gordonii and Streptococcus angionosis facilitates a divergent PAM sequence from the “NGG” PAM of SpCas9.
-
公开(公告)号:US20180282722A1
公开(公告)日:2018-10-04
申请号:US15820425
申请日:2017-11-21
Applicant: Massachusetts Institute of Technology
Inventor: Noah Jakimo , Pranam Chatterjee , Joseph M. Jacobson
Abstract: A chimeric DNA:RNA guide for very high accuracy Cas9 genome editing employs nucleotide-type substitutions in nucleic acid-guided endonucleases for enhanced specificity. The CRISPR-Cas9 gene editing system is manipulated to generate chimeric DNA:RNA guide strands to minimize the off-target cleavage events of the S. pyogenes Cas9 endonuclease. A DNA:RNA chimeric guide strand is sufficient to guide Cas9 to a specified target sequence for indel formation and minimize off-target cleavage events due to the specificity conferred by DNA-DNA interactions. Use of chimeric mismatch-evading lowered-thermostability guides (“melt-guides”) demonstrate that nucleotide-type substitutions in the spacer can reduce cleavage of sequences mismatched by as few as a single base pair. The chimeric mismatch-evading lowered-thermostability guides replace most gRNA spacer positions with DNA bases to suppress mismatched targets under Cas9's catalytic threshold.
-
公开(公告)号:US20250066750A1
公开(公告)日:2025-02-27
申请号:US18795872
申请日:2024-08-06
Applicant: Massachusetts Institute of Technology
Inventor: Joseph M. Jacobson , Noah Michael Jakimo , Pranam Chatterjee
Abstract: A Streptococcus canis Cas9 (ScCas9) ortholog and its engineered variants, possessing novel PAM specificity, is an addition to the family of CRISPR-Cas9 systems. ScCas9 endonuclease is used in complex with guide RNA, consisting of identical non-target-specific sequence to that of the guide RNA SpCas9, for specific recognition and activity on a DNA target immediately upstream of either an “NNGT” or “NNNGT” PAM sequence. A novel DNA-interacting loop domain within ScCas9, and other Cas9 orthologs, such as those from Streptococcus gordonii and Streptococcus angionosis facilitates a divergent PAM sequence from the “NGG” PAM of SpCas9.
-
10.
公开(公告)号:US20240141309A1
公开(公告)日:2024-05-02
申请号:US18220808
申请日:2023-07-11
Applicant: Massachusetts Institute of Technology
Inventor: Pranam Chatterjee , Noah Michael Jakimo , Joseph M. Jacobson
CPC classification number: C12N9/22 , C12N15/11 , C12N15/85 , C12N2310/20 , C12N2800/80
Abstract: Engineered Streptococcus canis Cas9 (ScCas9) variants include an ScCas9 protein with its PID being the PID amino acid composition of Streptococcus pyogenes Cas9 (SpCas9-NG, an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 in its amino acid sequence (Sc+), and an ScCas9 protein having a threonine-to-lysine substitution mutation at position 1227 and a substitution of residues ADKKLRKRSGKLATE [SEQ ID No. 4] in position 365-379 in the ScCas9 open reading frame (Sc++). Also included are CRISPR-associated DNA endonucleases with a PAM specificity of 5′-NG-3′ or 5′-NNG-3′ and a method of altering expression of a gene product by utilizing the engineered ScCas9 variants.
-
-
-
-
-
-
-
-
-